Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2023-04-25

Clinical Trial Update: Effect of Heavy Alcohol Consumption on Farnesoid X Receptor (FXR) Signaling [NA]

View source ↗

Summary

A completed clinical trial evaluated how heavy alcohol consumption affects Farnesoid X Receptor (FXR) signaling.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Suthat Liangpunsakul | Conditions: Alcohol Consumption | NA | Status: COMPLETED | Results posted: 2023-04-25